Eli Lilly: The One-Way Ride Can't Last Forever (Rating Downgrade)
Source: SeekingAlpha
2026-03-06 09:30:00 ET
Eli Lilly: Are The Best Days Over?
It seems like the market is ready to look past the previous winners in the healthcare sector, and that includes Eli Lilly ( LLY ), unfortunately. It shouldn't have escaped the lens of investors that LLY gained just under 7% in the past one year. While it is undoubtedly way ahead of its archrival Novo Nordisk’s ( NVO ) catastrophic 56% decline in the past 1 year, LLY appears to be trailing some of its healthcare peers right now....
Read the full article on Seeking Alpha
For further details see:
Eli Lilly: The One-Way Ride Can't Last Forever (Rating Downgrade)
Novo Nordisk - Class B
NASDAQ: NONOF
NONOF Trading
1.93% G/L:
$38.755 Last:
48,985 Volume:
$37.4975 Open:
NONOF Latest News
NONOF Stock Data
$217,715,792,624
1,607,906,287
N/A
1546
N/A
Biotechnology & Life Sciences
Healthcare
DK
Bagsvaerd
